Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause

Neurology

Volumn 69, Issue 11, 2007, Pages 1074-1083

  Rocca, W A ^a,b   Bower, J H ^a   Maraganore, D M ^a   Ahlskog, J E ^a   Grossardt, B R ^b   De Andrade, M ^b   Melton, L J ^a  

^a Department of Health Sciences Research   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; ESTROGEN DEFICIENCY; FEMALE; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENOPAUSE; NEUROPROTECTION; OVARIECTOMY; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 34948829010     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000276984.19542.e6     Document Type: Article

References (46)

1. McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocr Rev 1999;20:279-307.
2. Monk D, Brodaty H. Use of estrogens for the prevention and treatment of Alzheimer's disease. Dement Geriatr Cogn Disord 2000;11:1-10.
3. Gibbs RB, Aggarwal P. Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline. Horm Behav 1998;34:98-111.
4. Markowska AL, Savonenko AV. Effectiveness of estrogen replacement in restoration of cognitive function after long-term estrogen withdrawal in aging rats. J Neurosci 2002;22:10985-10995.
5. Xu H, Gouras GK, Greenfield JP, et al. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat Med 1998;4:447-451.
6. Huang J, Guan H, Booze RM, Eckman CB, Hersh LB. Estrogen regulates neprilysin activity in rat brain. Neurosci Lett 2004;367:85-87.
7. Chen S, Nilsen J, Brinton RD. Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications. Endocrinology 2006;147:5303-5313.
8. Morrison JH, Brinton RD, Schmidt PJ, Gore AC. Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women. J Neurosci 2006;26:10332-10348.
9. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 1998;279:688-695.
10. LeBlanc ES, Janowsky J, Chan BK, Nelson HD. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 2001;285:1489-1499.
11. Hogervorst E, Williams J, Budge M, Riedel W, Jolles J. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in postmenopausal women: a meta-analysis. Neuroscience 2000;101:485-512.
12. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2651-2662.
13. Rapp SR, Espeland MA, Shumaker SA, et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2663-2672.
14. Espeland MA, Rapp SR, Shumaker SA, et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2959-2968.
15. Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2947-2958.
16. Resnick SM, Henderson VW. Hormone therapy and risk of Alzheimer disease: a critical time. JAMA 2002;288:2170-2172.
17. Henderson VW, Benke KS, Green RC, Cupples LA, Farrer LA. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiatry 2005;76:103-105.
18. Zandi PP, Carlson MC, Plassman BL, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 2002;288:2123-2129.
19. Siegfried T. Neuroscience: It's all in the timing. Nature 2007;445:359-361.
20. Gibbs RG. Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol Aging 2000;21:107-116.
21. Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton LJ 3rd . Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 2006;7:821-828.
22. Manson JE, Bassuk SS, Harman SM, et al. Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause 2006;13:139-147.
23. Melton LJ 3rd, Bergstralh EJ, Malkasian GD, O'Fallon WM. Bilateral oophorectomy trends in Olmsted County, Minnesota, 1950-1987. Epidemiology 1991;2:149-152.
24. Melton LJ 3rd . History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266-274.
25. Brandt J, Spencer M, Folstein M. The telephone interview for cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1988;1:111-117.
26. Welsh KA, Breitner JCS, Magruder-Habib KM. Detection of dementia in the elderly using telephone screening of cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1993;6:103-110.
27. Plassman BL, Newman TT, Welsh KA, Helms M, Breitner JCS. Properties of the telephone interview for cognitive status. Application in epidemiological and longitudinal studies. Neuropsychiatry Neuropsychol Behav Neurol 1994;7:235-241.
28. Silverman JM, Breitner JC, Mohs RC, Davis KL. Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. Am J Psychiatry 1986;143:1279-1282.
29. Rocca WA, Peterson BJ, McDonnell SK, et al. The Mayo Clinic Family Study of Parkinson's Disease: study design, instruments, and sample characteristics. Neuroepidemiology 2005;24:151-167.
30. Gallo JJ, Breitner JC. Alzheimer's disease in the NASNRC Registry of aging twin veterans, IV. Performance characteristics of a two-stage telephone screening procedure for Alzheimer's dementia Psychol Med 1995;25:1211-1219.
31. Beeri MS, Werner P, Davidson M, Schmidler J, Silverman J. Validation of the modified telephone interview for cognitive status (TICS-m) in Hebrew. Int J Geriatr Psychiatry 2003;18:381-386.
32. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
33. Marks NF, Shinberg DS. Socioeconomic status differences in hormone therapy. Am J Epidemiol 1998;148:581-593.
34. Rocca WA, Bower JH, Maraganore DM, et al. Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology e-Pub ahead of print August 29, 2007.
35. Siddle N, Sarrel P, Whitehead M. The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril 1987;47:94-100.
36. Dean S. Hysterectomy and bone mineral density. Br J Hosp Med 1997;57:207-209.
37. Ahn EH, Bai SW, Song CH, et al. Effect of hysterectomy on conserved ovarian function. Yonsei Med J 2002;43:53-58.
38. Wierman ME, Basson R, Davis SR, et al. Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab 2006;91:3697-3710.
39. Yaffe K, Barnes D, Lindquist K, et al. Endogenous sex hormone levels and risk of cognitive decline in an older biracial cohort. Neurobiol Aging 2007;28:171-178.
40. Snieder H, MacGregor AJ, Spector TD. Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause. J Clin Endocrinol Metab 1998;83:1875-1880.
41. Weel AE, Uitterlinden AG, Westendorp IC, et al. Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J Clin Endocrinol Metab 1999;84:3146-3150.
42. Galvin JE, Roe CM, Xiong C, Morris JC. Validity and reliability of the AD8 informant interview in dementia. Neurology 2006;67:1942-1948.
43. Fiske A, Gatz M, Aadnoy B, Pedersen NL. Assessing age of dementia onset: validity of informant reports. Alzheimer Dis Assoc Disord 2005;19:128-134.
44. Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol 2005;106:219-226.
45. Buist DS, Newton KM, Miglioretti DL, et al. Hormone therapy prescribing patterns in the United States. Obstet Gynecol 2004;104:1042-1050.
46. Craig MC, Maki PM, Murphy DG. The Women's Health Initiative Memory Study: findings and implications for treatment. Lancet Neurol 2005;4:190-194.